The new strategy would continue the current vaccine approval process for people ages 65 and older and younger people with health problems that put them at high risk, according to an articlepublished Tuesday in The New England Journal of Medicine.
The new strategy would continue the current vaccine approval process for people ages 65 and older and younger people with health problems that put them at high risk, according to an articlepublished Tuesday in The New England Journal of Medicine.
I absolutely agree. My comment was merely a tidbit of information to throw out there for people to put in their tool belt, for “just in case.”
Understood, I’m just in a salty mood.